Search - tctmd.com

Displaying 601 - 620 of 673

Sort: Relevancy | Date

News Daily News

TCTMD’s Top 10 Most Popular News Stories From 2011

Jason Kahn

March 08, 2012

News Daily News

Stent Thrombosis Risk Lower with Xience vs. First-Generation DES

Yael L. Maxwell

March 06, 2012

News Daily News

El Riesgo de Trombosis del Stent es Menor con Xience que con SLF de 1ª Generación

Yael L. Maxwell

March 06, 2012

News Daily News

Sheath Size Associated with Radial Occlusion After Transradial PCI

Jason Kahn

March 06, 2012

News Daily News

Meta-Analysis: Mixed Results Seen with First-Gen DES in STEMI Patients

March 05, 2012

News Daily News

Similar Mortality Rates Seen in Men and Women with NSTE ACS

L.A. McKeown

January 26, 2012

Presentation Cell Therapy 2012

LATE-TIME: Delayed Delivery of Bone Marrow-Derived Stem Cells Following STEMI

Presenter: Timothy Henry

January 25, 2012

Presentation TCT 2012

Very Late Hazard with Primary Stenting versus Primary PTCA for STEMI: A 16 Year Single Center Experience

Presenter: Bruce R. Brodie, Yashashwi Pokharel, Ankit Garg, Charles Hansen, Sally Milks, Michael Cooper, Christopher McAlhany, Thomas Stuckey

January 03, 2012

News Daily News

Higher Intra-aortic Balloon Use Fails to Help in High-Risk PCI

Jason Kahn

December 11, 2011

News Daily News

LIPSIA: No Rush for Treatment of High-Risk NSTEMI Patients

Leah Lawrence

December 08, 2011

News Daily News

FFR-Guidance Demonstrates Benefits in Patients with Unstable Angina, NSTEMI

L.A. McKeown

December 08, 2011

News Conference News

ISAR-REACT 4: Bivalirudin Reduces Major Bleeding in NSTEMI Patients

November 13, 2011

News Industry News

Head-to-head comparison of two second generation drug-eluting coronary stents demonstrates non-inferiority

November 10, 2011

News Industry News

Use of drug-eluting balloons with bare metal stents do not show superiority over drug-eluting stents

November 09, 2011

News Conference News

RIFLE STEACS: Radial Approach Safer Than Femoral in STEMI

November 09, 2011

News Industry News

OrbusNeich Introduces the Combo™ Dual Therapy Stent at TCT 2011

November 09, 2011

News Conference News

ADAPT-DES: Risk of Early Stent Thrombosis in DES Predicted by Platelet Inhibition

November 09, 2011

News Industry News

Clinical trial supports radial artery access as preferable to femoral artery for angioplasty

November 09, 2011

News Industry News

Risk of late stent thrombosis continues for up to seven years in patients with first generation drug-eluting stents; risk factors identified

November 08, 2011

News Conference News

Preclinical Results Promising for Combo Stent

November 08, 2011

Advertisement

TCTMD’s Top 10 Most Popular News Stories From 2011

Stent Thrombosis Risk Lower with Xience vs. First-Generation DES

El Riesgo de Trombosis del Stent es Menor con Xience que con SLF de 1ª Generación

Sheath Size Associated with Radial Occlusion After Transradial PCI

Meta-Analysis: Mixed Results Seen with First-Gen DES in STEMI Patients

Similar Mortality Rates Seen in Men and Women with NSTE ACS

LATE-TIME: Delayed Delivery of Bone Marrow-Derived Stem Cells Following STEMI

Very Late Hazard with Primary Stenting versus Primary PTCA for STEMI: A 16 Year Single Center Experience

Higher Intra-aortic Balloon Use Fails to Help in High-Risk PCI

LIPSIA: No Rush for Treatment of High-Risk NSTEMI Patients

FFR-Guidance Demonstrates Benefits in Patients with Unstable Angina, NSTEMI

ISAR-REACT 4: Bivalirudin Reduces Major Bleeding in NSTEMI Patients

Head-to-head comparison of two second generation drug-eluting coronary stents demonstrates non-inferiority

Use of drug-eluting balloons with bare metal stents do not show superiority over drug-eluting stents

RIFLE STEACS: Radial Approach Safer Than Femoral in STEMI

OrbusNeich Introduces the Combo™ Dual Therapy Stent at TCT 2011

ADAPT-DES: Risk of Early Stent Thrombosis in DES Predicted by Platelet Inhibition

Clinical trial supports radial artery access as preferable to femoral artery for angioplasty

Risk of late stent thrombosis continues for up to seven years in patients with first generation drug-eluting stents; risk factors identified

Preclinical Results Promising for Combo Stent

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content